https://resilience.com/blog/how-early-phase-companies-can-future-proof-their-cell-therapies
Eytan Abraham on how should early-phase biotech companies approach Process and Analytical Development (PAD) and manufacturing to maximize cell therapy program...
cell therapiesearlyphasecompaniesfuture
https://biobridgeglobal.org/industry/bbg-advanced-therapies-first-cell-donation/
Oct 22, 2025 - The world’s only mobile leukapheresis center recorded its first cell donation on Monday, Oct. 20, marking the beginning of a new era for global healthcare.
advanced therapiesbbgcollectsfirstcell
https://fibrobiologics.com/
Nov 17, 2025 - Fibrobiologics is treating and curing common chronic diseases with next generation fibroblast cell-based therapies.
chronic diseasescellbasedtherapies
https://www.clinicaltrialsarena.com/sponsored/the-resurgence-of-mesenchymal-stem-cell-therapies/
Nov 20, 2025 - Mesenchymal stem cells have been explored across a wide range of diseases due to their potential to reduce inflammation and promote tissue repair and...
stem cellclinical trialsresurgencetherapiesarena
https://www.zeta.com/facility-type/cell-gene-therapies/
Oct 16, 2025 - Overcome complexity in patient-specific cellular therapy (PSCT). ZETA supports scale-up, closed systems, and GMP compliance for CGT manufacturing.
cellampgenetherapieszeta
https://www.sartorius.com/en/company/newsroom/corporate-news/sartorius-expands-production-of-key-components-for-cell-and-gene-therapies-in-france-1747896?ban_position=corpcom_big&ban_name=cc_20250915_Illkirch
September 18, 2025 - Sartorius has expanded the site of its French subgroup Sartorius Stedim Biotech in Illkirch, near Strasbourg. The state-of-the-art...
key componentssartoriusexpandsproductioncell
https://www.drugdiscoverytrends.com/how-price-safety-and-efficacy-shape-the-cell-and-gene-therapy-landscape/
Apr 26, 2024 - Cell and gene therapies offer groundbreaking treatments, but their high costs (up to $4.25 million) raise accessibility concerns.
costscellgenetherapies
https://www.biopharmadive.com/news/roche-arsenalbio-cell-therapy-cancer-solid-tumors/632736/
Rival companies have set a standard in lymphoma and leukemia. Now the Swiss drugmaker wants to be a pioneer in cell treatments for solid tumors.
rochepaysanotherbidcatch
https://www.bioworld.com/media/podcasts/532-bioworld-insider-podcast/play/50-gene-and-cell-therapies-will-propel-innovation-says-astellas-cco
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
cell therapiesgenepropelinnovationsays
https://www.thermofisher.com/blog/behindthebench/manufacturing-car-t-cell-therapies-challenges-insights-and-solutions/
Sep 9, 2024 - Since the first personalized cell therapy to treat advanced leukemia was approved by the US FDA in 2017, multiple CAR T cell therapies have been commercialized...
cell therapiesmanufacturingcarchallengesinsights
https://give.brighamandwomens.org/primary-topic/donor-story/
Gifts from Jeffrey and Lisa Leiden and the Vertex Foundation will help speed gene and cell therapies to patients with serious diseases.
clinical trialscell therapiesleidencentergene
https://www.statnews.com/2025/03/25/cell-gene-therapies-cgt-biotechnology-alliance-regenerative-medicine/
Mar 25, 2025 - Tim Hunt, CEO of the Alliance for Regenerative Medicine, explains “the incredibly promising but nonlinear world of cell and gene therapies.”
cellgenetherapiesseensetbacks
https://link.springer.com/book/10.1007/978-3-031-44080-9?error=cookies_not_supported&code=c41c0aeb-7fd1-4540-87d3-219d74d37ba1
This Open Access 8th ed. of the EBMT book addresses the latest developments and innovations in hematopoietic stem cell transplantation and cellular therapy
handbookcelltransplantationtherapiesspringerlink